FMS 6-K
Fresenius Medical Care AG (FMS)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of May 2024
Commission file number: 001-32749
FRESENIUS MEDICAL CARE AG
(Translation of registrant's name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXHIBITS
The following exhibits are being furnished with this Report:
| Exhibit 99.1 | Voting Instruction Card for holders of ADRs representing ordinary shares of Fresenius Medical Care AG. |
|---|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: May 3, 2024
| Fresenius Medical Care AG | |
|---|---|
| By: | /s/ Helen Giza |
| Name: | Helen Giza |
| Title: | Chief Executive Officer and Chair of the Management Board |
| By: | /s/ Martin Fischer |
| --- | --- |
| Name: | Martin Fischer |
| Title: | Chief Financial Officer and member of the Management Board |
Exhibit 99.1
| 24-8764 Fresenius Medical Register VIF Proof 2<br>Annual General Meeting of<br>Fresenius Medical Care AG<br>Date: May 16, 2024<br> See Instructions On Reverse Side.<br>Please make your marks like this: x Use pen only<br>• Mark, sign and date your Voting Instruction Form.<br>• Detach your Voting Instruction Form.<br>• Return your Voting Instruction Form in the<br>postage-paid envelope provided.<br> MAIL<br><br>_____________________________________ __________________________<br>Please Sign Here Please Date Above<br><br>_____________________________________ __________________________<br>Please Sign Here Please Date Above<br> Please separate carefully at the perforation and return just this portion in the envelope provided.<br><br>Authorized Signatures - This section must be<br>completed for your instructions to be executed.<br>EVENT #<br>CLIENT #<br>Annual General Meeting of<br>Fresenius Medical Care AG<br>to be held May 16, 2024<br>For ADR Holders of Record as of March 28, 2024<br>All votes must be received prior to 12:00 p.m. New York City Time May 9, 2024 (the “Cutoff Date”).<br>Copyright © 2024 Mediant Communications Inc. All Rights Reserved<br>PROXY TABULATOR FOR<br>FRESENIUS MEDICAL CARE AG<br>P.O. BOX 8016<br>CARY, NC 27512-9903<br> Directors<br>Recommend<br>For Against Abstain Agenda<br>1. Presentation of the adopted annual financial statements<br>and the approved consolidated financial statements, the<br>management reports for Fresenius Medical Care AG and the<br>group, the explanatory report by the Management Board on<br>the information pursuant to sec. 289a, 315a of the German<br>Commercial Code (Handelsgesetzbuch) and the report by the<br>Supervisory Board of Fresenius Medical Care AG for fiscal<br>year 2023<br>2. Resolution on the allocation of distributable profit<br>3. Resolution on the approval of the actions of the former<br>General Partner Fresenius Medical Care Management AG for<br>fiscal year 2023<br>4. Resolution on the approval of the actions of the members<br>of the Management Board of Fresenius Medical Care AG for<br>fiscal year 2023<br>5. Resolution on the approval of the actions of the members of<br>the Supervisory Board of Fresenius Medical Care AG & Co.<br>KGaA for fiscal year 2023<br>6. Resolution on the approval of the actions of the members of<br>the Supervisory Board of Fresenius Medical Care AG for fiscal<br>year 2023<br>7. Election of the auditor and group auditor for fiscal year 2024,<br>the auditor of sustainability reporting for fiscal year 2024 as<br>well as the auditor for the potential review of the half-year<br>financial report for fiscal year 2024 and other interim financial<br>information<br>8. Resolution on the approval of the compensation report for<br>fiscal year 2023<br>9. Resolution on the approval of the compensation system for<br>the members of the Management Board<br>10. Resolution on the remuneration of the members of the<br>Supervisory Board as well as a corresponding amendment of<br>Article 14 of the Articles of Association of the Company<br>11. Resolution on an amendment of Article 16 (1) of the<br>Articles of Association of the Company (Attendance at the<br>General Meeting and Exercise of the Voting Right) due to an<br>amendment of the German Stock Corporation Act<br>24-8764 Fresenius Medical Register VIF.indd 1 3/21/2024 1:57:53 PM |
|---|
| 24-8764 Fresenius Medical Register VIF Proof 2<br>FRESENIUS MEDICAL CARE AG<br>Instructions to The Bank of New York Mellon, as Depositary Bank<br>Must be received prior to 12:00 p.m. New York City time on May 9, 2024 (the “Cutoff Date”)<br>The undersigned registered holder of one or more American Depositary Receipts<br>(“Receipts”) of Fresenius Medical Care AG (the “Company”) hereby requests and instructs The<br>Bank of New York Mellon, as Depositary Bank, to vote or cause to be voted in accordance with the<br>instructions marked on the reverse side hereof, the number of shares of the Company represented<br>by such Receipt(s) registered in the name of the undersigned on the books of the Depositary Bank<br>as of the close of business on March 28, 2024, at the Annual General Meeting of Shareholders of<br>Fresenius Medical Care AG to be held on May 16, 2024, in respect of the agenda items specified in<br>the invitation to the Annual General Meeting.<br>NOTES:<br>1. Please direct the Depositary how to vote by placing an X in the box opposite the resolutions<br>on the reverse side.<br>2. The Depositary shall not vote or attempt to exercise the right to vote that attaches to the<br>deposited Shares, other than in accordance with instructions given by owners and received<br>by the Depositary, save as provided in 3 below.<br>3. If no instructions are received by the Depositary from an Owner with respect to a matter on<br>or before the Cutoff Date and the Depositary has received a written confirmation from the<br>Company by the business day following the Cutoff Date that (x) the Company reasonably<br>does not know of any substantial opposition to the matter and (y) the matter is not materially<br>adverse to the interests of shareholders, then the Depositary shall deem that Owner to have<br>instructed the Depositary to give a proxy to a person designated by the Company to vote<br>the number of deposited shares represented by that number of American Depositary Shares<br>as to that matter as proposed and therefore recommended by the Company’s Management<br>Board or the Company’s Supervisory Board; or, if no written confirmation has been provided<br>to abstain from voting as to that number of deposited Shares and that matter.<br>In order to protect the environment and better meet the changing user behavior of investors, the<br>Company has decided to reduce the amount of paper used for this event to the extent possible.<br>Therefore, please find below the web link to access the invitation to the Annual General Meeting<br>and the additional documents: https://www.freseniusmedicalcare.com/en/agm/<br>A printed copy of the invitation to the Annual General Meeting and the additional documents may<br>be obtained from Bank of New York Mellon, as Depositary Bank free of charge upon request.<br>If you do not have access to the internet and would like to obtain a hard copy, please write to:<br>Proxy Services Corp<br>10 Drew Court - Suite #3<br>Ronkonkoma, NY 11779<br>You may also request a hard copy of the materials by calling the toll free number 1-800-555-2470.<br>PROXY TABULATOR FOR<br>FRESENIUS MEDICAL CARE AG<br>P.O. Box 8016<br>CARY, NC 27512-9903<br>24-8764 Fresenius Medical Register VIF.indd 2 3/21/2024 1:57:53 PM |
| --- |